1. Home
  2. ELBM vs LNSR Comparison

ELBM vs LNSR Comparison

Compare ELBM & LNSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Electra Battery Materials Corporation

ELBM

Electra Battery Materials Corporation

HOLD

Current Price

$0.51

Market Cap

60.9M

Sector

Miscellaneous

ML Signal

HOLD

Logo LENSAR Inc.

LNSR

LENSAR Inc.

HOLD

Current Price

$5.35

Market Cap

69.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELBM
LNSR
Founded
2011
2004
Country
Canada
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical Electronics
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
60.9M
69.1M
IPO Year
2022
2005

Fundamental Metrics

Financial Performance
Metric
ELBM
LNSR
Price
$0.51
$5.35
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
1
Target Price
$2.15
$10.00
AVG Volume (30 Days)
302.6K
40.6K
Earning Date
05-12-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$58,435,000.00
Revenue This Year
N/A
$10.06
Revenue Next Year
$28.71
$41.48
P/E Ratio
N/A
N/A
Revenue Growth
N/A
9.24
52 Week Low
$0.50
$5.06
52 Week High
$8.70
$13.32

Technical Indicators

Market Signals
Indicator
ELBM
LNSR
Relative Strength Index (RSI) 40.13 36.19
Support Level $0.50 $5.34
Resistance Level $0.60 $6.47
Average True Range (ATR) 0.03 0.20
MACD -0.00 -0.05
Stochastic Oscillator 7.67 4.49

Price Performance

Historical Comparison
ELBM
LNSR

About ELBM Electra Battery Materials Corporation

Electra Battery Materials Corp is building North America's fully integrated, localized, and environmentally sustainable battery materials park. Electra Battery Materials is an integral part of the North American battery supply chain, providing low-carbon, sustainable, and traceable raw materials for the region's fast growing electric vehicle industry. The Company's operating segments are Refinery, Exploration and Evaluation, Corporate and Other.

About LNSR LENSAR Inc.

LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia (excluding South Korea), South Korea, and Other.

Share on Social Networks: